Yuan-chin P. Lee
Kaohsiung, KHQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Corrigendum to "Inhibition of Sp1-mediated survivin and MCL1 expression cooperates with SLC35F2 and myeloperoxidase to modulate YM155 cytotoxicity to human leukemia cells" [Biochem. Pharmacol.188 (2021) 114544].
Journal: Biochemical pharmacology
Published: June 20, 2024
Hydroquinone-selected chronic myelogenous leukemia cells are sensitive to chloroquine-induced cytotoxicity via MCL1 suppression and glycolysis inhibition.
Journal: Biochemical pharmacology
Published: August 09, 2023
BCL2L1 inhibitor A-1331852 inhibits MCL1 transcription and triggers apoptosis in acute myeloid leukemia cells.
Journal: Biochemical pharmacology
Published: April 13, 2023
Amsacrine downregulates BCL2L1 expression and triggers apoptosis in human chronic myeloid leukemia cells through the SIDT2/NOX4/ERK/HuR pathway.
Journal: Toxicology and applied pharmacology
Published: February 10, 2023
AMPK inhibition induces MCL1 mRNA destabilization via the p38 MAPK/miR-22/HuR axis in chronic myeloid leukemia cells.
Journal: Biochemical pharmacology
Published: November 25, 2022
Cytarabine-induced destabilization of MCL1 mRNA and protein triggers apoptosis in leukemia cells.
Journal: Biochemical pharmacology
Published: November 11, 2022
Carboxyl Group-Modified Myoglobin Induces TNF-α-Mediated Apoptosis in Leukemia Cells.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: August 12, 2022
Carboxyl group-modified myoglobin shows membrane-permeabilizing activity.
Journal: Archives of biochemistry and biophysics
Published: April 16, 2022
Functional and structural properties of cardiotoxin isomers produced by blocking negatively charged groups.
Journal: Archives of biochemistry and biophysics
Published: January 02, 2022
BCL2 inhibitor ABT-199 and BCL2L1 inhibitor WEHI-539 coordinately promote NOXA-mediated degradation of MCL1 in human leukemia cells.
Journal: Chemico-biological interactions
Published: December 23, 2021
Hydroquinone destabilizes BIM mRNA through upregulation of p62 in chronic myeloid leukemia cells.
Journal: Biochemical pharmacology
Published: December 10, 2021
CREB/Sp1-mediated MCL1 expression and NFκB-mediated ABCB1 expression modulate the cytotoxicity of daunorubicin in chronic myeloid leukemia cells.
Journal: Toxicology and applied pharmacology
Published: October 21, 2021
Last Updated: 09/26/2026